13D/13G Filings - NABRIVA THERAPEUTICS PLC (NBRVF)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-09
09:22 am
Purchase
2022-02-0813GNabriva Therapeutics plc
NBRVF
FMR LLC88,638
3.847%
31,468increase
(+55.04%)
Filing
History
2021-11-19
12:57 pm
Purchase
2021-11-1213GNabriva Therapeutics plc
NBRVF
Lincoln Park Capital Fund LLC180,504
7.960%
180,504increase
(New Position)
Filing
History
2021-02-08
10:35 am
Purchase
2021-02-0513GNabriva Therapeutics plc
NBRVF
FMR LLC57,170
6.780%
57,170increase
(New Position)
Filing
History
2020-02-12
4:32 pm
Purchase
2019-12-3113GNabriva Therapeutics plc
NBRVF
Longitude Capital Partners II LLC17,026
4.500%
977increase
(+6.08%)
Filing
History
2020-02-07
11:26 am
Purchase
2020-02-0613GNabriva Therapeutics plc
NBRVF
FMR LLC24,528
6.485%
24,528increase
(New Position)
Filing
History